The discovery of new antimicrobial agents as a means
of treating
drug-resistant microbial pathogens is of utmost significance to overcome
their immense risk to human well-being. The current investigation
involves the development, synthesis, and assessment of the antimicrobial
efficacy of novel quinoline derivatives incorporating a thiosemicarbazide
functionality. To design the target compounds (QST1–QST14), we applied the molecular hybridization approach to
link various thiosemicarbazides to the quinoline core with a sulfonyl
group. Upon the synthesis and completion of structural characterization
via spectroscopic techniques (1H NMR, 13C NMR, 15N NMR, IR, and HRMS), the title molecules were extensively
evaluated for their potential antitubercular, antibacterial, and antifungal
activities. N-(3-Chlorophenyl)-2-(quinolin-8-ylsulfonyl)hydrazine-1-carbothioamide
(QST4), the most effective compound against Mycobacterium tuberculosis H37Rv, was also tested
on isoniazid-resistant clinical isolates with katG and inhA promoter mutations. Based on molecular
docking studies, QST4 was also likely to demonstrate
its antimycobacterial activity through inhibition of the InhA enzyme.
Furthermore, three derivatives (QST3, QST4, and QST10) with preferable antimicrobial and drug-like
profiles were also shown to be nontoxic against human embryonic kidney
(HEK) cells. All compounds were optimized by the density functional
theory method using B3LYP with the 6-31+G(d,p) basis set. Structural
analysis, natural bond orbital calculations of donor–acceptor
interactions, molecular electrostatic potential analysis, and frontier
molecular orbital analysis were carried out. Quantum chemical descriptors
and charges on the atoms were determined to compare the strengths
of the intramolecular hydrogen bonds formed and their stabilities.
We determined that the sulfur atom forms a stronger intramolecular
hydrogen bond than the nitrogen, oxygen, and fluorine atoms in these
sulfonyl thiosemicarbazide derivatives.